Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Immunofluorescence Assay Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Immunofluorescence Assay Market Trends and Forecast

The future of the global immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers. The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of CAGR of 5.9% from 2023 to 2028. The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.
Immunofluorescence Assay Market by Type, Product, Disease, and End Use

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below. 
Immunofluorescence Assay Market by Segments

Immunofluorescence Assay Market by Segment

The study includes trends and forecast for the global immunofluorescence assay market by type, product, disease, end use, and region, as follows:

Immunofluorescence Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Indirect Immunofluorescence
  • Direct Immunofluorescence

Immunofluorescence Assay Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Antibodies
  • Reagents
  • Kits
  • Instruments
  • Consumables and Accessories

Immunofluorescence Assay Market by Disease [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Other

Immunofluorescence Assay Market by End Use [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Hospitals & Diagnostic Centers

Immunofluorescence Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Immunofluorescence Assay Companies

Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunofluorescence assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the immunofluorescence assay companies profiled in this report include- 
           

Immunofluorescence Assay Market Insights

  • Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.  
  • Within this market, the pharmaceutical & biotechnology companies are expected to witness the highest growth over the forecast period due to increasing use of these assays in the study of various diseases and drug discovery & development processes.
  • North America is expected to witness the highest growth over the forecast period due to rising incidence of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of major key players in the region.

Features of the Immunofluorescence Assay Market

  • Market Size Estimates: Immunofluorescence assay market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Immunofluorescence assay market size by various segments, such as type, product, disease, end use, and region
  • Regional Analysis: Immunofluorescence assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different types, products, diseases, end uses, and regions for the immunofluorescence assay market.
  • Strategic Analysis: This includes M&A, new type development, and competitive landscape for the immunofluorescence assay market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the immunofluorescence assay market size?
Answer: The global immunofluorescence assay market is expected to reach an estimated $4.0 billion by 2028.
Q2. What is the growth forecast for immunofluorescence assay market?
Answer: The global immunofluorescence assay market is expected to grow with a CAGR of 5.9% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the immunofluorescence assay market?
Answer: The major drivers for this market are increasing incidences of chronic diseases, growing government investments in healthcare, and rising R&D activities for technological advancements.
Q4. What are the major segments for immunofluorescence assay market?
Answer: The future of the immunofluorescence assay market looks promising with opportunities in the academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers.
Q5. Who are the key immunofluorescence assay companies?
Answer: Some of the key immunofluorescence assay companies are as follows:
 
  • Thermo Fisher Scientific
  • Abcam
  • Bio-Rad Laboratories
  • Becton Dickinson and Company
  • Nikon Corporation
Q6. Which immunofluorescence assay segment will be the largest in future?
Answer: Lucintel forecasts that indirect immunofluorescence is expected to witness the highest growth over the forecast period as it ensures flexibility and better amplification of the signal. Also, it is more economical as compared to direct immunofluorescence.
Q7. In immunofluorescence assay market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to rising incidence of chronic & infectious diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of major key players in the region.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the global immunofluorescence assay market by type (indirect immunofluorescence and direct Immunofluorescence), product (antibodies, reagents, kits, instruments, and consumables and accessories), disease (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, and other), end use (academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

For any questions related to immunofluorescence assay market or related to immunofluorescence assay companies, immunofluorescence assay market size, immunofluorescence assay market share, immunofluorescence assay analysis, immunofluorescence assay market growth, immunofluorescence assay market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Immunofluorescence Assay Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2017 to 2028
3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
3.2: Global Immunofluorescence Assay Market Trends (2017-2022) and Forecast (2023-2028)
3.3: Global Immunofluorescence Assay Market by Type
3.3.1: Indirect Immunofluorescence
3.3.2: Direct Immunofluorescence
3.4: Global Immunofluorescence Assay Market by Product
3.4.1: Antibodies
3.4.2: Reagents
3.4.3: Kits
3.4.4: Instruments
3.4.5: Consumables and Accessories
3.5: Global Immunofluorescence Assay Market by Disease
3.5.1: Cancer
3.5.2: Infectious Diseases
3.5.3: Cardiovascular Diseases
3.5.4: Autoimmune Diseases
3.5.9: Other
3.6: Global Immunofluorescence Assay Market by End Use
3.6.1: Academic & Research Institutes
3.6.2: Pharmaceutical & Biotechnology Companies
3.6.3: Contract Research Organizations
3.6.4: Hospitals & Diagnostic Centers
 
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
4.1: Global Immunofluorescence Assay Market by Region
4.2: North American Immunofluorescence Assay Market
4.2.1: North American Immunofluorescence Assay Market by Type: Indirect Immunofluorescence and Direct Immunofluorescence
4.2.2: North American Immunofluorescence Assay Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Hospitals & Diagnostic Centers
4.3: European Immunofluorescence Assay Market
4.3.1: European Immunofluorescence Assay Market by Type: Indirect Immunofluorescence and Direct Immunofluorescence 
4.3.2: European Immunofluorescence Assay Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Hospitals & Diagnostic Centers 
4.4: APAC Immunofluorescence Assay Market 
4.4.1: APAC Immunofluorescence Assay Market by Type: Indirect Immunofluorescence and Direct Immunofluorescence 
4.4.2: APAC Immunofluorescence Assay Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Hospitals & Diagnostic Centers 
4.5: ROW Immunofluorescence Assay Market 
4.5.1: ROW Immunofluorescence Assay Market by Type: Indirect Immunofluorescence and Direct Immunofluorescence
4.5.2: ROW Immunofluorescence Assay Market by End Use: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Hospitals & Diagnostic Centers
 
5. Competitor Analysis
5.1: Type Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Immunofluorescence Assay Market by Type 
6.1.2: Growth Opportunities for the Global Immunofluorescence Assay Market by Product
6.1.3: Growth Opportunities for the Global Immunofluorescence Assay Market by Disease
6.1.4: Growth Opportunities for the Global Immunofluorescence Assay Market by End Use
6.1.3: Growth Opportunities for the Global Immunofluorescence Assay Market by Region 
6.2: Emerging Trends in the Global Immunofluorescence Assay Market 
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Immunofluorescence Assay Market 
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunofluorescence Assay Market 
6.3.4: Certification and Licensing
 
7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Abcam 
7.3: Bio-Rad Laboratories
7.4: Becton Dickinson and Company
7.5: Nikon Corporation 
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Immunofluorescence Assay Market: Trends, Opportunities and Competitive Analysis [2023-2028] Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Immunofluorescence Assay Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?